PH20587A - Halogenophenyl glyceride esters - Google Patents

Halogenophenyl glyceride esters

Info

Publication number
PH20587A
PH20587A PH29022A PH29022A PH20587A PH 20587 A PH20587 A PH 20587A PH 29022 A PH29022 A PH 29022A PH 29022 A PH29022 A PH 29022A PH 20587 A PH20587 A PH 20587A
Authority
PH
Philippines
Prior art keywords
esters
halogenophenyl
glyceride esters
bromo
chloro
Prior art date
Application number
PH29022A
Other languages
English (en)
Inventor
Jean-Claude Arnould
John Raymond Evans
Geraint Jones
David Summers Thomson
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of PH20587A publication Critical patent/PH20587A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
PH29022A 1982-06-18 1983-06-08 Halogenophenyl glyceride esters PH20587A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP82401119 1982-06-18

Publications (1)

Publication Number Publication Date
PH20587A true PH20587A (en) 1987-02-20

Family

ID=8189916

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29022A PH20587A (en) 1982-06-18 1983-06-08 Halogenophenyl glyceride esters

Country Status (25)

Country Link
US (1) US4587262A (cs)
EP (1) EP0099177B1 (cs)
JP (1) JPS5951240A (cs)
KR (1) KR840005068A (cs)
AT (1) ATE21686T1 (cs)
AU (1) AU562207B2 (cs)
CA (1) CA1221983A (cs)
CS (2) CS241061B2 (cs)
DD (1) DD210029A5 (cs)
DE (1) DE3365634D1 (cs)
DK (1) DK278283D0 (cs)
ES (3) ES523376A0 (cs)
FI (1) FI832227A7 (cs)
GB (1) GB8313634D0 (cs)
GR (1) GR79196B (cs)
HU (1) HU191531B (cs)
IE (1) IE55531B1 (cs)
IL (1) IL68950A (cs)
NO (1) NO832203L (cs)
NZ (1) NZ204625A (cs)
PH (1) PH20587A (cs)
PL (1) PL242535A1 (cs)
PT (1) PT76889B (cs)
ZA (1) ZA834135B (cs)
ZW (1) ZW12983A1 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8313634D0 (en) * 1982-06-18 1983-06-22 Ici Plc Halogenophenyl glyceride esters
US4642366A (en) * 1984-03-05 1987-02-10 Stauffer Chemical Company Process for preparing methyl phosphonamides
CN1237151A (zh) * 1996-11-12 1999-12-01 塔马尔金药物革新有限公司 治疗皮肤疾病的方法
JP4226324B2 (ja) 2000-11-10 2009-02-18 学校法人早稲田大学 カルボン酸型脂質
FR2839448A1 (fr) * 2002-05-07 2003-11-14 Oreal Utilisation d'esters de triclosan, de piroctone et de tropolone dans une composition a liberation controlee
US8026285B2 (en) 2007-09-04 2011-09-27 Bezwada Biomedical, Llc Control release of biologically active compounds from multi-armed oligomers
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
US8053591B2 (en) 2007-09-26 2011-11-08 Bezwada Biomedical, Llc Functionalized biodegradable triclosan monomers and oligomers for controlled release
WO2012177986A2 (en) 2011-06-22 2012-12-27 Vyome Biosciences Conjugate-based antifungal and antibacterial prodrugs
JP6749890B2 (ja) * 2014-08-12 2020-09-02 モナッシュ ユニバーシティ リンパ指向プロドラッグ
WO2017041139A1 (en) 2015-09-08 2017-03-16 Monash University Lymph directing prodrugs
AU2018324037A1 (en) 2017-08-29 2020-04-16 Monash University Lymphatic system-directing lipid prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
WO2022140458A1 (en) * 2020-12-21 2022-06-30 The Research Foundation For The State University Of New York Penetrating cryoprotection agents and methods of making and using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3506720A (en) * 1963-02-22 1970-04-14 Geigy Chem Corp Halogenated hydroxy-diphenyl ethers
NL133434C (cs) * 1963-02-22 1972-02-15
CH431780A (de) * 1963-02-22 1967-03-15 Geigy Ag J R Reinigungsmittel
FR1441499A (fr) * 1964-02-14 1966-06-10 Geigy Ag J R Nouveaux esters phényliques doués de propriétés antimicrobiennes, utilisables en particulier pour la protection des matériaux organiques
GB1051823A (cs) * 1964-02-14
GB8313634D0 (en) * 1982-06-18 1983-06-22 Ici Plc Halogenophenyl glyceride esters

Also Published As

Publication number Publication date
IE831435L (en) 1983-12-18
AU1569883A (en) 1985-10-03
AU562207B2 (en) 1987-06-04
DD210029A5 (de) 1984-05-30
ES8505921A1 (es) 1985-06-16
IE55531B1 (en) 1990-10-24
ATE21686T1 (de) 1986-09-15
ES8500318A1 (es) 1984-10-01
FI832227A0 (fi) 1983-06-17
DE3365634D1 (de) 1986-10-02
NO832203L (no) 1983-12-19
ES523376A0 (es) 1984-10-01
HU191531B (en) 1987-03-30
CS445683A2 (en) 1985-07-16
DK278283D0 (da) 1983-06-16
PL242535A1 (en) 1984-09-24
PT76889A (en) 1983-07-01
CS241088B2 (en) 1986-03-13
FI832227L (fi) 1983-12-19
US4587262A (en) 1986-05-06
ES8601295A1 (es) 1985-11-01
ZA834135B (en) 1984-04-25
EP0099177B1 (en) 1986-08-27
PT76889B (en) 1986-01-24
FI832227A7 (fi) 1983-12-19
ES530745A0 (es) 1985-11-01
CS394384A2 (en) 1985-07-16
JPS5951240A (ja) 1984-03-24
IL68950A (en) 1988-05-31
CA1221983A (en) 1987-05-19
CS241061B2 (en) 1986-03-13
GR79196B (cs) 1984-10-22
NZ204625A (en) 1985-10-11
KR840005068A (ko) 1984-11-03
ES530744A0 (es) 1985-06-16
ZW12983A1 (en) 1985-01-30
GB8313634D0 (en) 1983-06-22
EP0099177A1 (en) 1984-01-25

Similar Documents

Publication Publication Date Title
ZW12983A1 (en) Halogenophenyl glyceride esters
HUT35642A (en) Process for preparing mevalonolactone analogues and derivatives thereof further pharmaceutical compositions containing such compounds
ES8307794A1 (es) Un procedimiento para la preparacion de agentes antifugicos triazolicos.
CA1259998C (cs)
AU523229B2 (en) Imidazo-(2,1-b)-(1,3,4)-thiadiazole
JO1704B1 (en) New potent compounds
IE830712L (en) 1,2,4-triazoles.
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU1628988A (en) Pharmaceutical compositions containing higher alcohols for the treatment of prostatic pathologies
ZA811664B (en) Substituted ethan-1-ols, their preparation and therapeutic agents containing these compounds
ES8205810A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
EP0440249A3 (en) Ethanolamine for the treatment of keloid
EP0548558A3 (en) Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases
ZA943342B (en) The use of compositions for combating tumour diseases
FI851365A0 (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
IL97509A0 (en) Lipid lowering compositions comprising bambuterol
IL99236A0 (en) Pharmaceutical composition for the topical treatment of psoriasis
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.
GB2012164A (en) Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts
GR82094B (cs)
GR871526B (en) Medicine for fighting the psoriasis and the eczema